Doppler Findings in the Fetal Cerebral Blood Vessels (VA/MCA) Within 24 Hours Before Delivery and Relation With Perinatal Outcome.
1 other identifier
observational
120
1 country
1
Brief Summary
- 1.Assess differences in flow patterns in the fetal cerebral blood vessels within 24 hours before delivery between fetuses with a normal vs. adverse perinatal outcome.
- 2.Explore maternal and/or fetal characteristics that might influence technical feasibility of doppler sonography of the fetal cerebral blood vessels in early labor at term.
- 3.Assess reliability of the technique by measuring intra- and inter-observer variation in a subset of participants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 25, 2022
CompletedFirst Posted
Study publicly available on registry
October 31, 2022
CompletedStudy Start
First participant enrolled
December 23, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJuly 1, 2024
June 1, 2024
2.8 years
October 25, 2022
June 28, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Differences in VPR (Vertebro-Placental Ratio) between fetuses/neonates with a composite perinatal outcome score < 3 / => 3
VPR measured in early labor (=< 4cm of cervical dilatation) - perinatal outcome score assessed at delivery - timespan between both observations variable, expected <12 hours.
Secondary Outcomes (2)
Differences in other doppler parameters (PI VA, PI MCA, CPR) between fetuses/neonates with a composite perinatal outcome score < 3 / => 3.
VPR measured in early labor (=< 4cm of cervical dilatation) - perinatal outcome score assessed at delivery - timespan between both observations variable, expected <12 hours.
Differences in maternal and fetal characteristics between successful and unsuccessful doppler examinations (observations) of the fetal VA and MCA respectively.
Assessed in early labor (=< 4cm of cervical dilatation)
Study Arms (1)
Term gestation
Interventions
Combined trans-abdominal and trans-perineal ultrasound examination
Eligibility Criteria
"Low-risk" pregnant women
You may qualify if:
- Singleton pregnancy.
- Term gestation (37-42 weeks).
- Fetus in cephalic presentation.
- No known fetal chromosomal or (severe) congenital anomaly.
- Normally grown fetus (ultrasound scan demonstrating normal fetal growth between 30-37 weeks of gestation, defined as an estimated fetal weight/abdominal circumference \> 10th centile or crossing \<2 quartiles compared to earlier growth ultrasound).
- Absence of pre-existing doppler or amniotic fluid abnormalities.
- Normal fetal heart rate tracing / CTG (excluding pre-existing hypoxia).
- Admission in early spontaneous labor or induction of labor with expected delivery \< 24 hours.
- Maternal age \>= 18 years
- Willing to give written informed consent.
You may not qualify if:
- Advanced labor (\> 4cm of cervical dilatation) at the time of admission on the labor ward.
- Severe pre-existing chronic maternal medical condition or poor obstetric history/antenatal complications associated with increased risk of adverse perinatal outcome (non-exhaustive e.g.: uncontrolled chronic hypertension, severe pre-eclampsia, uncontrolled (gestational) diabetes, maternal sepsis, major antepartum haemorrhage, intra-uterine infection, prolonged rupture of membranes \> 18 hours, etc.).
- Intra-uterine fetal demise / death.
- Prelabour rupture of membranes with meconium-stained amniotic fluid.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospitals Leuven, department of obstetrics and gynaecology
Leuven, 3000, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jute Richter, MD, PhD
UZ Leuven / KU Leuven
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 25, 2022
First Posted
October 31, 2022
Study Start
December 23, 2022
Primary Completion
September 30, 2025
Study Completion
December 31, 2025
Last Updated
July 1, 2024
Record last verified: 2024-06